CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Unisplendour Guhan Group Corporation Ltd Company Snapshot
Business Description:
Unisplendour Guhan Group Corporation Ltd operates in the Pharmaceutical preparations sector. Unisplendour Guhan Group Corporation Limited is principally engaged in the manufacture and sale of pharmaceuticals. The Company provides Chinese medicines, including Chinese healthcare products, medicines for cold treatment and anti hyperlipemia medicines, among others; chemical drugs, including clindamycin phosphate for injection, lomefloxacin hydrochloride for injection and levofloxacin lactate for injection, among others, as well as biological products, including human albumin and human immunoglobulin. The Company distributes its products in domestic markets. In our complete report available for purchase the company is compared to: Sichuan Dikang Sci & Tech Pharma.Ind., Ltd., Skystar Bio-Pharmaceutical Company and Jiangsu Liahuan Pharmaceutical Co., Ltd..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Unisplendour Guhan Group Corporation Ltd
  Stock Performance Chart for Unisplendour Guhan Group Corporation Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 8.96
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 13.0%  
4 Weeks -22.2%   52 Weeks -32.8%  
 
Unisplendour Guhan Group Corporation Ltd Key Data:
  Ticker: 000590 Country: CHINA
  Exchanges: SZN Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 311,625,000
(Year Ending Jan 2011).
Employees: 2,184
  Currency: Chinese Renmimbi Market Cap: 1,819,134,688
  Fiscal Yr Ends: December Shares Outstanding: 203,028,425
  Share Type: A Gu Closely Held Shares: N/A
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.